NewsBenzingaAktis Oncology第三季度每股收益为$(0.54),低于$(0.48)的预期;销售额为390.5万美元,低于401.6万美元的预期。 Aktis Oncology第三季度每股收益为$(0.54),低于$(0.48)的预期;销售额为390.5万美元,低于401.6万美元的预期。 Benzinga 2026.11.12 13:21 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy Rating on Sharplink With $13 Price Target Tencent's Q3 Revenue Up 8% YoY to RMB 207.3 Billion Realty Income vs. Agree Realty: Which REIT Wins on Dividends and Growth? Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage Is Wall Street Bullish or Bearish on Solventum Stock?
Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled
FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage